Navigation Links
UCSF-Tanzania get $7.5M from Gates Foundation for partnership to train African health workers
Date:1/6/2009

The University of California, San Francisco has received a $7.5 million grant from the Bill & Melinda Gates Foundation to address the shortage of healthcare workers in Tanzania. The two-year grant will support a strategic collaboration between UCSF Global Health Sciences and the Muhimbili University of Health Allied Sciences (MUHAS) in Tanzania to develop, implement and document strategies to enable MUHAS and other African institutions to meet their countries' health workforce needs.

UCSF and MUHAS will work together to develop a partnership and gather preliminary data to inform a long-term, sustainable partnership. UCSF Professor Sarah Macfarlane and MUHAS Professor Ephata Kaaya lead the collaboration.

Solving sub-Saharan Africa's healthcare worker shortage has long been a priority for governments, universities and international organizations, according to the collaborators. Tanzania's leaders recognize the need to educate and train more health care workers, they said. This project harnesses the resources of two major universities to approach the problem and aims to develop an institutional partnership model that can be replicated in other low-resource settings.

Faculty from the UCSF schools of medicine, nursing, pharmacy and dentistry will work with their MUHAS counterparts, as well as the MUHAS School of Public Health, to share curricula and educational technologies, and develop collaborative research programs.

"Through this collaboration, MUHAS will recruit and train faculty, strengthen the academic environment for education and research, and revise undergraduate and post-graduate curricula in order to increase its output of health professionals to serve the needs of the country," said MUHAS Vice Chancellor and Professor Kisali Pallangyo.

This grant will enable MUHAS, the only public university of health sciences in Tanzania, to plan and build capacity to meet Tanzania's long-term need for healthcare professi
'/>"/>

Contact: Kristen Bole
kbole@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. USC receives $7.5M for Comprehensive Center of Excellence in Minority Health
2. Blind Man Navigates Obstacle Course Without Error
3. Event Honoring Bill Gates Raises Over $1.5 Million for Sustainable Agriculture Research at The Hebrew University of Jerusalem
4. Think Tank Investigates the Environmental Conditions Surrounding Health Inequities
5. Accordia Global Health Foundation Receives $12.5 Million Grant From Bill & Melinda Gates Foundation
6. Study investigates Gore-tex-type device to stop strokes and mini-strokes
7. CIO Healthcare Summit Announces Dates and VIP Delegates
8. SAFC Pharma Commissions HPAPI Conjugates Facility at St. Louis
9. New Study Confirms Link Between Pain Pumps and Cartilage Damage -- Searcy Denney Law Firm Investigates Claims
10. Daschle, Convention Delegates, Daughtry Join to Give Help to AIDS-Affected People Around the World
11. FDA Investigates Possible Vytorin-Cancer Link
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...amsy Darwish knows what it,s like being addicted t...called America,s "Other" Drug Problem Prescripti...sy shared his story of addiction and recovery and ...on Freedom Center drug and alcohol rehabilitatio.../mediaboom/09-0703-NarcononMI_72dpi.jpg ) , *(Ph...
(Date:7/3/2009)...-resistant strain, study finds , , F...istant tuberculosis might someday meet its match i... suggests a new study. , Researchers, led by ...o, report in the July 3 issue of PLoS Computation... and tolcapone have the potential to treat the dif...
(Date:7/3/2009)... will lead to treatments, , , FRIDAY, J...ey,ve found a major cellular flaw that may drive t... caught early, lung cancer can often be treated. B...s well advanced. Though doctors can sometimes put ...gs back more virulent than ever, frequently spread...
(Date:7/3/2009)...Newswire/ -- Republicans on the Senate Finance Com...orm legislation that would eliminate coverage for ...ld lose coverage for abortion services that their ...ns of uninsured women will still lack a basic heal...ter quality of life. , , If these senators are ...
Breaking Medicine News(10 mins):Health News:Narconon Graduate Successfully Recovers From Prescription Drug Abuse 2Health News:New Weapons in Fight Against TB? 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3
...cal condition that can cause slowness and instabil... of these problems say researchers. A pulse of ind... that control movement. This is done inorder to im...em move faster than they did before, without magne...
...mmon form of dementia in the elderly with typical ...and // behavioral changes. An early study of the d...e in treating Alzheimer's disease in people, accor...y found that treatment of a mouse form of AD with ...
...who have optic nerve damage are at increased risk ...e with visual impairment. The participants had the...and their results were compared with those of 12 y...chers discovered those with optic nerve disease we...
...ent of pregnant women suffer from depression and u...g pregnancy. Studies involving infants exposed to ...l effects, so most doctors believe these drugs can..., most studies have only compared major outcomes, ...
Other Medicine News:
(Date:6/29/2009)...N, England, June 29 Vantia Therape...ing novel, small molecule drugs,targeting large, ...sults from,a Phase IIa clinical trial of its lead...trial showed that oral VA106483 was successful in ...ic effect in patients, as determined by,increased...
(Date:6/28/2009)...DO CORONADO, Portugal, June 29 Dat... add-on treatment with the novel,once-daily anti...SL) resulted,in a marked and sustained decrease i... Results from the one-year extension of a pivotal...sented at the International Congress for Epilepsy ...
(Date:6/26/2009)...., June 26, and OSAKA, Japan, June 27, 2009 /PRNew...Takeda") today announced that Takeda Global Resear...United States (U.S.) subsidiary received on June 2...U.S. Food and Drug Administration (FDA) regarding ...iptin, a selective dipeptidyl peptidase IV (DPP-4)...
(Date:6/26/2009)...s release, "Agendia,s Breast Cancer Recurrence Tes... Expert Consensus Recommendations" issued,on 23 J...e, please be advised,that the subheadline was mis...by PR Newswire. Complete, corrected release follow...s Breast Cancer Recurrence Test MammaPrint Include...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3MinuteClinic Becomes Participating Provider With Preferred Blue Network of BlueCross BlueShield of South Carolina 35832 1MinuteClinic Becomes Participating Provider With Preferred Blue Network of BlueCross BlueShield of South Carolina 35832 2GlaxoSmithKline Reports Q4 and Year End Results 2008 10321 1Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 1Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 2Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 3Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 4Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 5Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 6Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 7Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 8Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 9Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 35827 10Rigel to Present at BIO CEO 26 Investor Conference 35822 1
...GIN: 0in 0in 0pt; LINE-HEIGHT: 150%; mso-hyphenate...ering nasal spray,could stop thousands of patients...as reported today1 at the 10th Congress of,the Eur...–9,June. The study investigated whether this...st onset of pain relief and short,duration of effe...
....--(BUSINESS WIRE)--Jun 8, 2007 - IMPAX Laboratori...r presentations,highlighting the company,s compou...ease carbidopa/levodopa (CD/LD) product to be,mark... Disorder,Society,s 11th International Congress of...anbul, Turkey on June 7, 2007. The poster,presenta...
Other Medicine Technology:Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 2IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 3IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 4
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: